FDA Approves First Rapid At-Home COVID Test
Global Stocks Hit All Time High On Stimulus Optimism Ahead Of Fed Meeting Tyler Durden Wed, 12/16/2020 - 07:40 Another overnight session, and - predictably -...
The U.S. Food and Drug administration authorized emergency use of the first over-the-counter Covid-19 antigen test, which can be used at home.
Last week, Moderna (MRNA) kicked off its TeenCOVE Study, dosing the first participants in the Phase 2/3 trial of the company’s Covid-19 vaccine candidate mRNA-1273, in...
Moderna Inc.’s Covid-19 vaccine appeared set for regulatory authorization after U.S. Food and Drug Administration staff endorsed it as safe and effective in released documents.
Favorable updates on potential COVID-19 vaccines have been a major catalyst for stock market movements in recent months. Both Pfizer and Moderna have been grabbing headlines...
As the coronavirus rages, a vaccine finally is available for certain groups of people and will soon be ready for other groups. But there are plenty...
After allegedly passing up an offer to acquire more doses of Pfizer and BioNTech’s Covid-19 vaccine last month, the US government is in negotiations to double...
Incyte and Novartis announced a Phase III study of Jakafi (ruxolitinib), a first-in-class JAK1/JAK2 inhibitor, failed to hit endpoints as a treatment for patients 12 and...
Stocks Jump On Vaccine Rollout, Hopes For Bipartisan Stimulus Bill Tyler Durden Mon, 12/14/2020 - 08:05 US equity futures jumped alongside European markets on Monday amid...
Pfizer and German partner BioNTech announced that they will start distributing the first batches of their BNT162b2 vaccine in the US in coming days after the...
Moderna has inked a deal to supply the US with another 100 million doses of its COVID-19 vaccine candidate, doubling the total amount of orders secured...
The United States hit a record 16 million Covid-19 cases on Dec. 12, with deaths closing in on the 300,000 mark, as millions of doses of...
Top U.S. Food and Drug Administration regulators said most Americans with allergies should be safe to receive the Covid-19 vaccine developed by Pfizer Inc. and Germany’s...
A U.S. Centers for Disease Control and Prevention advisory panel on Dec. 12 recommended the nation’s first COVID-19 vaccine, helping clear the way for public health...
The chief executive of Germany’s BioNTech SE said the biggest challenge facing the company and partner Pfizer Inc. now that their Covid-19 vaccine is authorized for...
The U.S. government will get an additional 100 million doses of Moderna Inc.'s Covid-19 vaccine candidate, expected to be delivered in the second quarter of 2021...
The United States authorized the use of Pfizer Inc’s Covid-19 vaccine on Dec. 11, with the first inoculations expected within days, marking a turning point in...
Markets have been turning mostly up since the election, as investors have taken the measure of the macro environment and appear pleased. There is some expectation...
AstraZeneca, which is jointly developing a Covid-19 vaccine with the University of Oxford, plans to begin clinical trials testing the company's vaccine in combination with Russia’s...
The U.S. Food and Drug Administration (FDA) has officially endorsed Pfizer and BioNTech’s COVID vaccine. That paves the way for emergency use authorization as the agency...
Advisers to the FDA have voted in favour of approving Pfizer and BioNTech’s COVID-19 vaccine, with a near-unanimous The post FDA advisers vote in favour of...
Shares of Pfizer and BioNTech rose in Thursday’s extended market session after an advisory panel to the US Food and Drug Administration (FDA) voted in favor...
Millions of Americans say they won't get the vaccine. Will money change their minds? And is luring them with cash the right approach?
Moderna (MRNA) stock has been one of 2020’s star performers, up 695%, and judging by its real-world results, many would say justifiably so. The biggest question...
The United States’ daily death toll from Covid-19 surpassed 3,000 for the first time, prompting pleas for Americans to scale back Christmas plans even with vaccines...
Moderna Inc. dosed the first participants in a mid-to-late stage study testing the company's Covid-19 vaccine candidate in adolescents aged 12 to less than 18, and...
Economic relief and a vaccine drew nearer to reality to counter a coronavirus pandemic that has ravaged the U.S. economy and killed 286,487 people with year-end...
Economic relief and a vaccine drew nearer to reality to counter a coronavirus pandemic that has ravaged the U.S. economy and killed 286,487 people with year-end...
After clinical trials showed no major side effects with Pfizer’s COVID vaccine, the U.K. is attaching a new warning after severe allergic reactions in two patients...